FPRX - Five Prime Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $3.37. This is a potential upside of $3.37 (0%) from yesterday's end of day stock price of $0.

Five Prime Therapeutics's activity chart (see below) currently has 28 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.33% with an average time for these price targets to be met of 230.4 days.

Most recent stock forecast was given by ETZER DAROUT from BMO on 09-Mar-2021. First documented stock forecast 15-Apr-2015.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

11

3 years 1 months 17 days ago

1/1 (100%)

$7.15 (185.71%)

50

Hold

38

11

3 years 1 months 18 days ago

5/5 (100%)

$0.24 (0.64%)

329

Hold

38

52

3 years 1 months 21 days ago

3/4 (75%)

$0.24 (0.64%)

116

Hold

28

$-10 (-26.32%)

28

3 years 1 months 22 days ago

4/5 (80%)

$-10 (-26.32%)

234

Buy

30

$-8 (-21.05%)

3 years 5 months 15 days ago

1/2 (50%)

$12 (66.67%)

113

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FPRX (Five Prime Therapeutics) average time for price targets to be met?

On average it took 230.4 days on average for the stock forecasts to be realized with a an average price target met ratio 66.33

Which analyst has the current highest performing score on FPRX (Five Prime Therapeutics) with a proven track record?

CHRISTOPHER MARAI

Which analyst has the most public recommendations on FPRX (Five Prime Therapeutics)?

Christopher Marai has 8 price targets and 6 ratings on FPRX

Which analyst is the currently most bullish on FPRX (Five Prime Therapeutics)?

Kennen Mackay with highest potential upside - $12

Which analyst is the currently most reserved on FPRX (Five Prime Therapeutics)?

Jim Birchenough with lowest potential downside - -$33

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?